Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Maternal smoking during pregnancy leaves its lasting mark on the child’s genetic make-up

No. 15a | 05/04/2016 | by Sel

If mothers smoke during pregnancy, they influence the epigenetic programming of their unborn child’s genetic make-up in the long term. This may give rise to an increased risk of the development of disease risks later in the child’s life. Researchers at the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, the German Cancer Research Center (DKFZ) in Heidelberg and the Heidelberg University discovered that these changes are not limited to individual regions of DNA. In fact, the researchers stated in the “Molecular Systems Biology” journal that they particularly accumulate in enhancers of gene expression.
Joint press release by the German Cancer Research Center and Heidelberg University

© Molecular Systems Biology

Maternal smoking during pregnancy is harmful to the unborn child as well as the mother. This is a known fact. “For the first time, we can now demonstrate that exposure to tobacco smoke also causes epigenetic changes in enhancers of gene expression,” said Irina Lehmann, Environmental Immunologist at the UFZ. These deregulated enhancers are distributed throughout the child’s entire genome.

Epigenetic changes form part of countless processes that occur during human development. The genetic material functions as a blueprint for all cells. In order for different cell types, e.g. liver or muscle cells, to develop, certain genes must be activated or deactivated at certain times. One of the ways this happens is through epigenetic changes which can be disrupted by various environmental factors. In their latest study, the group of researchers from Leipzig and Heidelberg revealed that epigenetic changes related to tobacco smoke increase the risk of children developing lung diseases.

The underlying data comes from the epidemiological study entitled LiNA (Lifestyle and environmental factors and their Influence on Newborns Allergy risk). In this study, researchers asked which environmental factors could have a negative influence on children’s health during pregnancy. In collaboration with the Municipal Hospital “St. Georg” in Leipzig, UFZ researchers have been monitoring 622 mothers and their children since 2006. The mothers underwent in-depth examinations for possible exposure to environmental factors during their pregnancy.

For their current work, two groups of mother-child pairs were examined: mothers who smoked during pregnancy and mothers who were not exposed to tobacco smoke. Together with the genome researchers working with Roland Eils at the DKFZ and the University of Heidelberg, the researchers examined the epigenome of the mothers and the children. They wanted to find out whether there was evidence of epigenetic changes in the smoker families that did not occur in the non-smoker families – and which consequences this may have for the children’s health. “We were able to find evidence of epigenetic changes in smoking mothers as well as in the umbilical cord blood of the newborn babies,” said Lehmann. The changes thus occur in the womb and affect the unborn child’s gene regulation.

The researchers determined that smoking particularly affects enhancer regions in the genome. Enhancers are DNA regions that regulate the expression of one or more genes. Lehmann explained that: “If an enhancer region is affected by the effects of smoking, this may lead to deregulation of several genes at the same time.” The researchers give an example of the consequences of a deregulated enhancer in their work: the enzyme JNK2 (c-Jun N-terminal protein kinase 2) plays a role in inflammatory responses. If the enhancer that activates JNK2 is now affected, this may increase the risk of lung diseases in the children’s later life.

The researchers also determined that the epigenetic effects observed in the umbilical cord blood at birth can still be seen several years after the child is born. However, it could not be ascertained beyond doubt whether these effects are long-term impacts of exposure to smoke prior to birth. “Children who are exposed to tobacco smoke even before being born usually continue to be exposed to this after their birth,” said Lehmann. She added that the prolonged exposure to cigarette smoke after birth may contribute to the observed stability of epigenetic changes.

In their analysis, the researchers identified more than 400 enhancers affected by tobacco smoke. They regulate genes that play a role in a variety of diseases such as diabetes, adiposity or even cancer. “This discovery will allow us to start understanding the mechanisms that make smoking the cause of such a wide range of diseases,” said Roland Eils.

The insights from this research are intended to provide starting points for new options for treating environmental diseases. “The better our understanding of deregulation caused by environmental factors, the better we will be able to respond to this. Nevertheless in the case of tobacco smoke, avoiding exposure is still the best alternative,” said Lehmann in summary.

Publication:
Bauer T, Trump S, Ishaque N, Thürmann L, Gu L, Bauer M, Bieg M, Gu Z, Weichenhan D, Mallm J, Röder S, Herberth G, Takada E, Mücke O, Winter M, Junge KM, Grützmann K, Rolle-Kampczyk U, Wang Q, Lawerenz C, Borte M, Polte T, Schlesner M, Schanne M, Wiemann S, Geörg C, Stunnenberg HG, Plass C, Rippe K, Mizuguchi J, Herrmann C, Eils R, Lehmann I (2016). Environment-induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children. Molecular Systems Biology http://dx.doi.org/10.15252/msb.20156520

This research was supported by the DKFZ’s Heidelberg Center for Personalized Oncology (DKFZ-HIPO).

Further information:

Dr. Irina Lehmann
UFZ Department of Environmental Immunology
Department of Environmental Immunology
+49 (0)341 235 1216
Irina.lehmann@ufz.de

and

Prof. Dr. Roland Eils
German Cancer Research Center and the Heidelberg University
+49 (0)6221 42 3601
r.eils@dkfz-heidelberg.de

or via

Susanne Hufe (UFZ Press Office)
Telephone: +49 (0)341-235-1635
E-mail: susanne.hufe@ufz.de

Dr. Stefanie Seltmann (DKFZ Press Office)
Tel.: +49 (0)6221-42-2854
E-mail: s.seltmann@Dkfz-Heidelberg.de

Marietta Fuhrmann-Koch (Heidelberg University Press Office)
Tel.: +49 (0)6221 54-19012
E-mail: kum@uni-heidelberg.de 

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS